{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:03:01Z","timestamp":1789552981246,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s11695-020-05170-3","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T10:03:13Z","timestamp":1610100193000},"page":"1304-1312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Metabolic Effects of Endoscopic Duodenal Mucosal Resurfacing: a Systematic Review and Meta-analysis"],"prefix":"10.1007","volume":"31","author":[{"given":"Guilherme Henrique Peixoto","family":"de Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo Turiani Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateus Pereira","family":"Funari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1844-8973","authenticated-orcid":false,"given":"Igor Braga","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanderley Marques","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Massaro Takamatsu","family":"Sagae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Jo\u00e3o Remi","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Mayo de Vieira","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Guimar\u00e3es Hourneaux","family":"de Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"5170_CR1","unstructured":"World Health Organization. Obesity and Overweigh. 2020 [cited 2020 Sep 12]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"5170_CR2","unstructured":"World Health Organization. Diabetes. 2020 [cited 2020 Dec 9]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes."},{"key":"5170_CR3","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s11695-020-04558-5","volume":"30","author":"APST Kotinda","year":"2020","unstructured":"Kotinda APST, de Moura DTH, Ribeiro IB, et al. Efficacy of intragastric balloons for weight loss in overweight and obese adults: a systematic review and meta-analysis of randomized controlled trials. Obes Surg. 2020;30:2743\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32300945","journal-title":"Obes Surg"},{"key":"5170_CR4","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s11695-020-04449-9","volume":"30","author":"AA de Miranda Neto","year":"2020","unstructured":"de Miranda Neto AA, de Moura DTH, Ribeiro IB, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. Obes Surg. 2020;30:1971\u201387. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32107706","journal-title":"Obes Surg"},{"key":"5170_CR5","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1210\/jc.2011-0585","volume":"96","author":"RH Eckel","year":"2011","unstructured":"Eckel RH, Kahn SE, Ferrannini E, et al. Obesity and type 2 diabetes: what can be unified and what needs to be individualized? J Clin Endocrinol Metab. 2011;96:1654\u201363. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21602457","journal-title":"J Clin Endocrinol Metab"},{"key":"5170_CR6","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/aje\/kwj141","volume":"163","author":"N Hartemink","year":"2006","unstructured":"Hartemink N, Boshuizen HC, Nagelkerke NJD, et al. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol. 2006;163:1042\u201352. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16611666","journal-title":"Am J Epidemiol"},{"key":"5170_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/ajcn\/84.2.427","volume":"84","author":"A Schienkiewitz","year":"2006","unstructured":"Schienkiewitz A, Schulze MB, Hoffmann K, et al. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)\u2013Potsdam Study1\u20133. Am J Clin Nutr. 2006;84:427\u201333. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16895894","journal-title":"Am J Clin Nutr"},{"key":"5170_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32278004","journal-title":"J Hepatol"},{"key":"5170_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/15111519","journal-title":"Diabetes Care"},{"key":"5170_CR10","first-page":"160","volume":"121","author":"PR Schauer","year":"2003","unstructured":"Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Trans Meet Am Surg Assoc. 2003;121:160\u201378. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14530719","journal-title":"Trans Meet Am Surg Assoc"},{"key":"5170_CR11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s00464-016-5082-8","volume":"31","author":"T Aldoheyan","year":"2017","unstructured":"Aldoheyan T, Hassanain M, Al-Mulhim A, et al. The effects of bariatric surgeries on nonalcoholic fatty liver disease. Surg Endosc. 2017;31:1142\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27405478","journal-title":"Surg Endosc"},{"key":"5170_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11695-018-3470-y","volume":"29","author":"EGH de Moura","year":"2019","unstructured":"de Moura EGH, Ribeiro IB, Fraz\u00e3o MSV, et al. EUS-guided Intragastric injection of botulinum toxin a in the preoperative treatment of super-obese patients: a randomized clinical trial. Obes Surg. 2019;29:32\u20139. Available from: http:\/\/link.springer.com\/10.1007\/s11695-018-3470-y","journal-title":"Obes Surg"},{"key":"5170_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1097\/01.sla.0000224726.61448.1b","volume":"244","author":"F Rubino","year":"2006","unstructured":"Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244:741\u20139. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17060767","journal-title":"Ann Surg"},{"key":"5170_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tige.2020.03.008","volume":"22","author":"TR McCarty","year":"2020","unstructured":"McCarty TR, Thompson CC. Bariatric and metabolic therapies targeting the small intestine. Tech Innov Gastrointest Endosc. 2020;22:145\u201353. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32905221","journal-title":"Tech Innov Gastrointest Endosc"},{"key":"5170_CR15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.gastro.2018.02.010","volume":"154","author":"ACG van Baar","year":"2018","unstructured":"van Baar ACG, Nieuwdorp M, Holleman F, et al. The duodenum harbors a broad untapped therapeutic potential. Gastroenterology. 2018;154:773\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29428335","journal-title":"Gastroenterology"},{"key":"5170_CR16","doi-asserted-by":"crossref","unstructured":"Mudaliar S, Henry RR. The incretin hormones: from scientific discovery to practical therapeutics. Diabetologia. 2012;55:1865\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22555471","DOI":"10.1007\/s00125-012-2561-x"},{"key":"5170_CR17","doi-asserted-by":"publisher","first-page":"E379","DOI":"10.1210\/jc.2010-1333","volume":"96","author":"FJ Verdam","year":"2011","unstructured":"Verdam FJ, Greve JWM, Roosta S, et al. Small intestinal alterations in severely obese hyperglycemic subjects. J Clin Endocrinol Metab. 2011;96:E379\u201383. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21084402","journal-title":"J Clin Endocrinol Metab"},{"key":"5170_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.giec.2016.12.002","volume":"27","author":"AD Cherrington","year":"2017","unstructured":"Cherrington AD, Rajagopalan H, Maggs D, et al. Hydrothermal duodenal mucosal resurfacing. Gastrointest Endosc Clin N Am. 2017;27:299\u2013311. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28292408","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"5170_CR19","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ."},{"key":"5170_CR20","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;"},{"key":"5170_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RAA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1\u201312. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/721797","journal-title":"Control Clin Trials"},{"key":"5170_CR22","unstructured":"GRADE Working Group. GRADEpro guideline development tool [software]. McMaster Univ. 2015."},{"key":"5170_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ [Internet]. 2003;327:557\u201360. Available from: http:\/\/www.bmj.com\/cgi\/doi\/10.1136\/bmj.327.7414.557","journal-title":"BMJ [Internet]"},{"key":"5170_CR24","doi-asserted-by":"crossref","unstructured":"Magee C, Everson M, Mok J, et al. PTH-040 Endoscopic duodenal mucosal resurfacing in type 2 diabetes \u2013 a single centre experience. Endoscopy. BMJ Publishing Group Ltd and British Society of Gastroenterology; 2018. p. A32.2-A32. Available from: http:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2018-BSGAbstracts.61","DOI":"10.1136\/gutjnl-2018-BSGAbstracts.61"},{"key":"5170_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jhepr.2019.10.006","volume":"1","author":"ACG van Baar","year":"2019","unstructured":"van Baar ACG, Beuers U, Wong K, et al. Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results. JHEP Reports. 2019;1:429\u201337. Available from:http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32039394","journal-title":"JHEP Reports"},{"key":"5170_CR26","doi-asserted-by":"crossref","unstructured":"van Baar ACG, Nieuwdorp M, Holleman F, et al. Single duodenal mucosal resurfacing elicits improvements in glycaemic and hepatic parameters in type 2 diabetes mellitus: Complete 1 year results from the first prospective multicenter study. United Eur Gastroenterol J. 2018;A135\u2013747. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/2050640618792819","DOI":"10.1016\/j.gie.2018.04.069"},{"key":"5170_CR27","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1016\/S0016-5085(16)30672-2","volume":"150","author":"MG Neto","year":"2016","unstructured":"Neto MG, Rajagopalan H, Becerra P, et al. 829 Endoscopic duodenal mucosal resurfacing improves glycemic and hepatic parameters in patients with type 2 diabetes: data from a first-in-human study. Gastroenterology. 2016;150:S174. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508516306722","journal-title":"Gastroenterology"},{"key":"5170_CR28","doi-asserted-by":"crossref","unstructured":"van Baar AC, Nieuwdorp M, Batterham R, et al. Improvement in hepatic transaminases over 12 months after single procedure duodenal mucosal resurfacing in type 2 diabetes patients. United Eur Gastroenterol J. 2017;A161\u2013836. Available from: http:\/\/journals.sagepub.com\/doi\/10.1177\/2050640617725676","DOI":"10.26226\/morressier.59a6b346d462b80290b54cd1"},{"key":"5170_CR29","doi-asserted-by":"publisher","first-page":"AB260","DOI":"10.1016\/j.gie.2019.03.293","volume":"89","author":"A van Baar","year":"2019","unstructured":"van Baar A, Smeele P, Vriend TM, et al. Sa1962 duodenal mucosal resurfacing (DMR) combined with GLP-1 receptor agonism may eliminate insulin treatment while maintaining glycaemic control and improving overall metabolic health in type 2 diabetes. Gastrointest Endosc. 2019;89:AB260. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016510719304845","journal-title":"Gastrointest Endosc"},{"key":"5170_CR30","doi-asserted-by":"crossref","unstructured":"Mraz M, Marcovitch I, Lankova I, et al. 1131-P: endoscopic duodenal submucosal laser ablation for the treatment of type 2 diabetes mellitus: results of first-in-human pilot study. Diabetes. 2019;68:1131-P. Available from: http:\/\/diabetes.diabetesjournals.org\/lookup\/doi\/10.2337\/db19-1131-P","DOI":"10.2337\/db19-1131-P"},{"key":"5170_CR31","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.2337\/dc16-0383","volume":"39","author":"H Rajagopalan","year":"2016","unstructured":"Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016;39:2254\u201361. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27519448","journal-title":"Diabetes Care"},{"key":"5170_CR32","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S0618-8278(19)30124-0","volume":"70","author":"G Aithal","year":"2019","unstructured":"Aithal G, Sakai N, Chouhan M, et al. PS-112-endoscopic duodenal mucosal resurfacing improves hepatic fat fraction, glycemic and lipid profiles in type 2 diabetes. J Hepatol. 2019;70:e70\u20131. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0618827819301240","journal-title":"J Hepatol"},{"key":"5170_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gutjnl-2019-318349","volume":"69","author":"ACG van Baar","year":"2020","unstructured":"van Baar ACG, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut. 2020;69:295\u2013303. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31331994","journal-title":"Gut"},{"key":"5170_CR34","doi-asserted-by":"crossref","unstructured":"Mingrone G, Hopkins D, Aithal G, et al. 121-LB: durable glycemic improvements after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (T2D): 48-week results from the REVITA-2 European cohort. Diabetes. 2020;121\u2013LB. Available from: http:\/\/diabetes.diabetesjournals.org\/lookup\/doi\/10.2337\/db20-121-LB","DOI":"10.2337\/db20-121-LB"},{"key":"5170_CR35","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/dc09-1727","volume":"33","author":"D Sherifali","year":"2010","unstructured":"Sherifali D, Nerenberg K, Pullenayegum E, et al. The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care. 2010;33:1859\u201364. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20484130","journal-title":"Diabetes Care"},{"key":"5170_CR36","doi-asserted-by":"crossref","unstructured":"Buhmann H, le Roux CW, Bueter M. The gut\u2013brain axis in obesity. Best Pract Res Clin Gastroenterol. 2014;28:559\u201371. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25194175","DOI":"10.1016\/j.bpg.2014.07.003"},{"key":"5170_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.tige.2020.03.003","volume":"22","author":"N van Olst","year":"2020","unstructured":"van Olst N, Meiring S, de Brauw M, et al. Small intestinal physiology relevant to bariatric and metabolic endoscopic therapies: Incretins, bile acid signaling, and gut microbiome. Tech Innov Gastrointest Endosc [Internet]. 2020;22:109\u201319. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590030720300878","journal-title":"Tech Innov Gastrointest Endosc [Internet]"},{"key":"5170_CR38","doi-asserted-by":"crossref","unstructured":"Nauck MA, Meier JJ. Incretin hormones: their role in health and disease. Diabetes, Obes Metab. 2018;20:5\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29364588","DOI":"10.1111\/dom.13129"},{"key":"5170_CR39","doi-asserted-by":"crossref","unstructured":"Vilar-Gomez E, Chalasani N. Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers. J Hepatol. 2018;68:305\u201315. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29154965","DOI":"10.1016\/j.jhep.2017.11.013"},{"key":"5170_CR40","doi-asserted-by":"crossref","unstructured":"Starekova J, Reeder SB. Liver fat quantification: where do we stand? Abdom Radiol. 2020;45:3386\u201399. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33025153","DOI":"10.1007\/s00261-020-02783-1"},{"key":"5170_CR41","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/hep.29797","volume":"68","author":"C Caussy","year":"2018","unstructured":"Caussy C, Reeder SB, Sirlin CB, et al. Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials. Hepatology. 2018;68:763\u201372. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/29356032","journal-title":"Hepatology"},{"key":"5170_CR42","unstructured":"Safety & effectiveness of duodenal mucosal resurfacing (DMR) using the Revita\u2122 system in treatment of type 2 Diabetes. [cited 2020 Dec 9]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03653091"},{"key":"5170_CR43","unstructured":"Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita\u2122 System in Subjects With Type 2 Diabetes on Insulin Therapy (REVITA-T2Di). [cited 2020 Dec 9]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04419779"},{"key":"5170_CR44","unstructured":"Effect of DMR in the Treatment of NASH (DMR_NASH_001). [cited 2020 Dec 9]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03536650"},{"key":"5170_CR45","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1055\/a-0862-0263","volume":"7","author":"EGH de Moura","year":"2019","unstructured":"de Moura EGH, Ponte-Neto AM, Tsakmaki A, et al. Histologic assessment of the intestinal wall following duodenal mucosal resurfacing (DMR): a new procedure for the treatment of insulin-resistant metabolic disease. Endosc Int Open. 2019;7:E685\u201390. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31098390","journal-title":"Endosc Int Open"},{"key":"5170_CR46","doi-asserted-by":"crossref","unstructured":"Pendyala S, Walker JM, Holt PR. A high-fat diet is associated with endotoxemia that originates from the gut. Gastroenterology. 2012;142:1100-1101.e2. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22326433","DOI":"10.1053\/j.gastro.2012.01.034"},{"key":"5170_CR47","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/dc12-2255","volume":"36","author":"GS Gerhard","year":"2013","unstructured":"Gerhard GS, Styer AM, Wood GC, et al. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Diabetes Care. 2013;36:1859\u201364. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23801799","journal-title":"Diabetes Care"},{"key":"5170_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.soard.2019.01.033","volume":"15","author":"NK Davies","year":"2019","unstructured":"Davies NK, O\u2019Sullivan JM, Plank LD, et al. Altered gut microbiome after bariatric surgery and its association with metabolic benefits: a systematic review. Surg Obes Relat Dis. 2019;15:656\u201365. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30824335","journal-title":"Surg Obes Relat Dis"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-05170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-020-05170-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-020-05170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T16:24:21Z","timestamp":1614615861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-020-05170-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5170"],"URL":"https:\/\/doi.org\/10.1007\/s11695-020-05170-3","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Moura reports personal fees from Boston Scientific, personal fees from Olympus, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Research Ethics Committee of the University of S\u00e3o Paulo School of Medicine <i>Hospital das Cl\u00ednicas<\/i>.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent Statement"}}]}}